Cas 1073254-49-5,d3-2-(2-chlorophenyl)-2-methylamino-cyclohexanone hydrochloride

1073254-49-5

Post Buying Request

Basic information

Product Name: d3-2-(2-chlorophenyl)-2-methylamino-cyclohexanone hydrochloride
Synonyms: d3-2-(2-chlorophenyl)-2-methylamino-cyclohexanone hydrochloride
CAS NO:1073254-49-5
Molecular Formula:
Molecular Weight: 277.166
EINECS: N/A
Product Categories: N/A
Mol File: 1073254-49-5.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: d3-2-(2-chlorophenyl)-2-methylamino-cyclohexanone hydrochloride(CAS DataBase Reference)
NIST Chemistry Reference: d3-2-(2-chlorophenyl)-2-methylamino-cyclohexanone hydrochloride(1073254-49-5)
EPA Substance Registry System: d3-2-(2-chlorophenyl)-2-methylamino-cyclohexanone hydrochloride(1073254-49-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1073254-49-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1073254-49-5 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

1073254-49-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1073254-49-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,3,2,5 and 4 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1073254-49:
(9*1)+(8*0)+(7*7)+(6*3)+(5*2)+(4*5)+(3*4)+(2*4)+(1*9)=135
135 % 10 = 5
So 1073254-49-5 is a valid CAS Registry Number.

1073254-49-5Upstream product

1073254-49-5Downstream Products

1073254-49-5Relevant articles and documents

SUBSTITUTED CYCLOHEXANONES

-

Page/Page column 27, (2008/12/04)

Disclosed herein are substituted cyclohexanone-based NMDA receptor modulators of Formula I, process of preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.